22 November 2016: There were a lot of different media reports flying around about the future of the TPP during the APEC meeting in Lima over the weekend. Here’s our explainer.
14 November 2016: Over the weekend, the US administration confirmed that they would not push the TPP through the current lame duck Congress: effectively abandoning the deal.
While Trump's election may have dealt the final blow, it's been people like you and organisations like ours which have campaigned since 2010 against the TPP's corporate agenda.
The TPP could still pass in a lame duck session of the US Congress held before Trump is sworn in to office in late January 2017.
11 November 2016: Even if the TPP never goes into effect, its damage will be felt worldwide - in the form of the election of President Donald Trump, writes Lori Wallach, director of Public Citizen’s Global Trade Watch.
November 10, 2016: The shock election of Donald Trump as the next US President does not necessarily mean the TPP will never be ratified, as some are predicting. In fact, the TPP could still pass the current lame duck Congress held before Mr Trump is sworn into office on January 20 next year.
6 November 2016: Peter Martin writes in Fairfax Media, that the RCEP is "another massive deal you've never heard of” which has ISDS on the agenda, despite the strong opposition ISDS has created to the TPP, and predicts the TPP’s demise . He cites a statement from hundreds of US law professors opposing ISDS because it would allow foreign investors to bypass "the basic procedures of the US justice system” .
MEDIA RELEASE, November 7 2016: “The Australian government should reject the push from US Republican Congress members to increase biologic medicine monopolies by seven years, even more than the extra three years which has already been agreed in the TPP text,” Dr Patricia Ranald, Convener of the Australian Fair Trade and Investment Network said today.